Methoxy polyethylene glycol-epoetin beta Terminated Phase 4 Trials for Anemia Treatment

TerminatedTreatment4 IdentifierTitleDrugs
NCT01066000A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia
NCT00576602A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant